0
Obstructive Lung Diseases |

Evaluation of Inhaler Technique and Patient Satisfaction With Fixed-Combination Budesonide/Formoterol Dry-Powder Inhaler in Chronic Obstructive Pulmonary Disease (COPD): Data on Real-Life Clinical Practice in Turkey

Can Ozturk, MD; Akin Kaya, MD; Cahit Bilgin, MD; Leyla Yucesoy, MD; Belgin Ikidag, MD; Mustafa Demirel, MD; Seyma Baslilar, MD; Bengu Saylan, MD; Tuncer Senol, MD; Semih Aganoglu, MD; Gonca Can, MD; Mustafa Dogrul, MD; Murat Cam, MD; Nezaket Erdogan, MD; Ozgur Batum, MD; Muzaffer Turan, MD; Cahit Demir, MD; Serife Torun, MD; Murat Cirit, MD; Mehmethan Turan, MD; Arif Kelesoglu, MD; Savas Yasar, MD; Oznur Uzunay, MD; Kevser Melek, MD; Osman Altiparmak, MD
Author and Funding Information

Gazi University Faculty of Medicine, Ankara, Turkey


Chest. 2013;144(4_MeetingAbstracts):726A. doi:10.1378/chest.1688796
Text Size: A A A
Published online

Abstract

SESSION TITLE: COPD Treatment Posters

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM

PURPOSE: To evaluate inhaler techniques and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler (DPI) chronic obstructive pulmonary disease (COPD) in Turkey in real-life clinical practice.

METHODS: A total of 442 patients with COPD (mean(SD) age: 63.2(10.6) years, 76.5% were males) were included in this cross-sectional study conducted at 25 outpatient clinics across Turkey. Data on socio-demographic characteristics, characteristics of COPD, inhaler technique and satisfaction with DPI were recorded at a single cross-sectional visit performed at the study enrolment.

RESULTS: Patients were characterized by prominence of moderate to severe (78.1%) COPD, high rate of regular use of overall COPD medications (89.4%) and Turbuhaler® for an average of 33.7 months, predominance of males (76.5%), primary education (85.7%), urban location (68.3), ex-smokers (61.1%) and spending time outdoors for ≥4hour/day (62.0%). Use of correct techniques was evident in majority of patients (≥94%), whereas inhalation maneuvers including breathing out gently away from mouthpiece without blowing into it (71.9%) and holding the breath for 5-10 seconds (78.3%) were performed correctly by lesser percent of patients especially in the older group (≥65 years, p<0.05). Overall percent of patients with the feeling that she/he used the inhaler very/fairly correctly was 73.3%, while 86% of patients identified that they were very/fairly satisfied with the inhaler, irrespective of age and educational status.

CONCLUSIONS: Our findings revealed the majority of patients are able to use Turbuhaler® correctly regardless of the educational status, while older age was associated with higher rate of errors in inhalation maneuvers. Majority of our patients identified Turbuhaler® to be very/fairly convenient regarding ease of use, portability, and usability.

CLINICAL IMPLICATIONS: Providing data on the common errors in inhalation technique in relation to socio-demographic determinants and patient satisfaction among patients with COPD in Turkey in the real-life clinical practice, our findings emphasize the positive role of regular monitoring in better clinical efficacy and disease control via achievement of good compliance to inhaler treatment and proper handling of inhalers in asthma patients.

DISCLOSURE: The following authors have nothing to disclose: Can Ozturk, Akin Kaya, Cahit Bilgin, Leyla Yucesoy, Belgin Ikidag, Mustafa Demirel, Seyma Baslilar, Bengu Saylan, Tuncer Senol, Semih Aganoglu, Gonca Can, Mustafa Dogrul, Murat Cam, Nezaket Erdogan, Ozgur Batum, Muzaffer Turan, Cahit Demir, Serife Torun, Murat Cirit, Mehmethan Turan, Arif Kelesoglu, Savas Yasar, Oznur Uzunay, Kevser Melek, Osman Altiparmak

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543